Human growth hormone agonist - Cyclo Therapeutics
Alternative Names: Oral hGH - Cyclo TherapeuticsLatest Information Update: 01 Jan 2024
At a glance
- Originator Applied Molecular Transport
- Class Growth hormones; Recombinant fusion proteins
- Mechanism of Action Insulin-like growth factor I stimulants; Somatotropin receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Somatotropin deficiency
Most Recent Events
- 27 Dec 2023 Applied Molecular Transport has merged with Cyclo Therapeutics to form Cyclo Therapeutics
- 21 Mar 2023 Discontinued - Preclinical for Somatotropin deficiency in USA (PO) (Applied Molecular Transport pipeline, March 2023)
- 21 Sep 2022 Preclinical trials in Somatotropin deficiency in USA (PO)